HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sheng Chen Selected Research

Econazole

1/2022Synergistic Antimicrobial Effect of Colistin in Combination with Econazole against Multidrug-Resistant Acinetobacter baumannii and Its Persisters.
1/2022Econazole as adjuvant to conventional antibiotics is able to eradicate starvation-induced tolerant bacteria by causing proton motive force dissipation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sheng Chen Research Topics

Disease

85Neoplasms (Cancer)
06/2022 - 06/2004
46Infections
12/2022 - 01/2006
32Inflammation (Inflammations)
07/2022 - 06/2008
32Breast Neoplasms (Breast Cancer)
02/2022 - 01/2012
16Brain Injuries (Brain Injury)
04/2022 - 12/2013
15Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
04/2022 - 08/2012
15Parkinson Disease (Parkinson's Disease)
01/2022 - 09/2006
13Squamous Cell Carcinoma of Head and Neck
01/2022 - 05/2010
12Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2022 - 10/2006
12Neoplasm Metastasis (Metastasis)
01/2022 - 01/2012
11Salmonella Infections (Salmonellosis)
12/2022 - 01/2004
11Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2016
9Bacterial Infections (Bacterial Infection)
08/2022 - 09/2015
9Triple Negative Breast Neoplasms
06/2020 - 01/2013
9Brain Edema (Cerebral Edema)
01/2020 - 10/2013
9Paralysis (Palsy)
07/2015 - 04/2006
8Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2022 - 08/2007
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2012
7Fibrosis (Cirrhosis)
01/2022 - 01/2012
7Hypoxia (Hypoxemia)
01/2022 - 11/2010
7Disease Progression
10/2021 - 09/2007
7Allergic Rhinitis
02/2021 - 06/2014
7Wounds and Injuries (Trauma)
01/2020 - 03/2005
7Stroke (Strokes)
10/2019 - 01/2013
6Starvation
02/2022 - 11/2020
6Neuroinflammatory Diseases
02/2022 - 10/2013
6Esophageal Squamous Cell Carcinoma
12/2021 - 01/2016
6Cholestasis
11/2021 - 01/2015
6Carcinogenesis
07/2020 - 09/2014
6Traumatic Brain Injuries (Traumatic Brain Injury)
01/2017 - 11/2010
5Necrosis
08/2022 - 02/2015
5Carcinoma (Carcinomatosis)
05/2022 - 06/2010
5Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 08/2013
5Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2004
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2007
5Neuroblastoma
01/2020 - 11/2008
5Botulism
01/2016 - 05/2012
4Pneumonia (Pneumonitis)
07/2022 - 01/2018
4Nervous System Diseases (Neurological Disorders)
06/2022 - 06/2009
4Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2017
4Myasthenia Gravis
01/2022 - 01/2021
4Lung Neoplasms (Lung Cancer)
11/2021 - 10/2003
4Cerebral Hemorrhage
02/2021 - 02/2014
4Obesity
01/2021 - 01/2012
4Central Nervous System Diseases (CNS Diseases)
01/2021 - 01/2016
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 01/2005
4Alzheimer Disease (Alzheimer's Disease)
12/2019 - 01/2007
4Residual Neoplasm
12/2019 - 12/2013
4Hemorrhage
10/2017 - 11/2010
4Laryngeal Neoplasms (Laryngeal Cancer)
02/2017 - 09/2014

Drug/Important Bio-Agent (IBA)

45Proteins (Proteins, Gene)FDA Link
06/2022 - 10/2003
24Anti-Bacterial Agents (Antibiotics)IBA
12/2022 - 01/2011
18Biomarkers (Surrogate Marker)IBA
10/2022 - 10/2003
17Pharmaceutical PreparationsIBA
08/2022 - 03/2008
14Carbapenems (Carbapenem Antibiotics)IBA
12/2022 - 08/2014
11Therapeutic UsesIBA
12/2020 - 06/2009
11Paclitaxel (Taxol)FDA LinkGeneric
12/2019 - 01/2012
10CytokinesIBA
01/2022 - 01/2012
10InflammasomesIBA
01/2022 - 10/2013
10Botulinum Toxins (Botulinum Toxin)IBA
01/2022 - 04/2006
9MicroRNAs (MicroRNA)IBA
04/2022 - 10/2017
9Neuroprotective AgentsIBA
01/2019 - 10/2006
8Reactive Oxygen Species (Oxygen Radicals)IBA
03/2022 - 06/2010
8Hormones (Hormone)IBA
09/2021 - 09/2012
8Peptides (Polypeptides)IBA
10/2020 - 01/2007
7Colistin (Coly-Mycin)FDA Link
01/2022 - 12/2016
7AntibodiesIBA
01/2021 - 01/2004
7Carboplatin (JM8)FDA LinkGeneric
01/2017 - 01/2012
6Ciprofloxacin (Cipro)FDA LinkGeneric
12/2022 - 01/2018
6Messenger RNA (mRNA)IBA
08/2022 - 04/2010
6AutoantibodiesIBA
06/2022 - 01/2004
6Long Noncoding RNAIBA
05/2022 - 03/2017
6EnzymesIBA
12/2021 - 11/2010
6Small Interfering RNA (siRNA)IBA
12/2020 - 10/2013
6Neurotransmitter Agents (Neurotransmitter)IBA
01/2016 - 04/2006
6Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2007 - 01/2004
5Ceftriaxone (Ceftriaxon)FDA LinkGeneric
12/2022 - 01/2004
5PolymersIBA
08/2022 - 01/2017
5AntioxidantsIBA
12/2021 - 11/2010
4Anti-Infective Agents (Microbicides)IBA
12/2022 - 01/2019
4Toll-Like Receptors (Toll-Like Receptor)IBA
08/2022 - 10/2014
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2022 - 01/2012
4NucleotidesIBA
01/2022 - 01/2018
4Tigecycline (Tygacil)FDA Link
01/2022 - 07/2018
4LipopolysaccharidesIBA
01/2022 - 10/2020
4Trastuzumab (Herceptin)FDA Link
01/2022 - 01/2015
4Lysine (L-Lysine)FDA Link
12/2021 - 01/2020
4Amino AcidsFDA Link
12/2021 - 01/2019
4Biological ProductsIBA
12/2021 - 12/2013
4RNA (Ribonucleic Acid)IBA
12/2021 - 12/2017
4Matrix Metalloproteinases (MMPs)IBA
11/2021 - 02/2014
4MelatoninIBA
01/2021 - 01/2016
4CateninsIBA
01/2020 - 02/2017
4SNARE Proteins (SNAREs)IBA
06/2009 - 04/2006

Therapy/Procedure

38Therapeutics
06/2022 - 09/2006
24Neoadjuvant Therapy
01/2022 - 01/2012
18Drug Therapy (Chemotherapy)
01/2022 - 10/2012
7Radiotherapy
09/2021 - 09/2010
6Immunotherapy
01/2022 - 01/2017
6Moxibustion
07/2020 - 05/2015